TAG ARCHIVES FOR webinar

4
Mar2021

On October 15, 2020, PRIM&R hosted a webinar, IRB Operations During a Pandemic. During this webinar, Jeremy N. Block, PhD, MPP; Dorean J. Flores, BS, MPA, CIP; and Hallie Kassan, MS, CIP discussed critical areas of IRB operations during a pandemic, including office, review, and meeting operations; protocol initiation, modification, termination, etc.; protocol operations, and examples of unethical conduct or scandals during the pandemic. Following the webinar, the speakers reflected on the session and attendee feedback. Read more

24
Aug2020

On April 14, 2020, PRIM&R hosted a webinar, Meaningful Metrics: How HRPPs Can Use Their Data Effectively. This webinar discussed how to effectively use data to assess HRPP performance. After the webinar, speaker Kim Serpico, MEd, CIP, EdD Candidate responded to attendee questions time didn't permit us to address live. We're pleased to share those responses with the readers of Ampersand. Read more

21
Apr2020

On October 23, 2019, PRIM&R hosted a webinar, Real-World Approaches to Informed Consent under the Revised Common Rule. This webinar served as a check-in on how the human subjects research oversight community is adapting to the new requirements, particularly the revised Common Rule's implications for informed consent. Presenters Karen Blackwell, MS, CIP; Patrick Herbison, MEd, CIP, and Ann Johnson, PhD, MPH, covered challenges and successes pertaining to informed consent requirements in the revised Common Rule and helped attendees identify strategies to benefit their organizations in adapting to the regulatory changes. After the webinar, the speakers responded to attendee questions time didn’t permit us to address live. We’re pleased to share those responses with the readers of Ampersand. Read more

6
Apr2020

The COVID-19 pandemic is impacting human subjects research in unprecedented ways. On March 23, PRIM&R hosted a forum to provide an opportunity to hear from HRPP leaders representing universities, academic health care systems, and an independent IRB on the key issues and strategies HRPPs should be considering and implementing in the face of the COVID-19 pandemic. After the webinar, the speakers responded to attendee questions time didn’t permit us to address live. We’re pleased to share those responses with the readers of Ampersand. Read more

16
Mar2020

Pediatric subjects participating in HHS-funded or FDA-regulated studies are afforded additional protections not codified in subpart A of the Federal Policy for the Protection of Human Subjects (the Common Rule). On September 18, 2019, PRIM&R hosted a webinar, Pediatric Risk Determination: IRB Considerations and Cases. Presented by Rich Gormon, MD, and Donna L. Snyder, MD, this webinar helped attendees understand pediatric subpart D regulations, identify criteria for pediatric approvable research, and evaluate if the interventions or procedures in a protocol hold the prospect of direct benefit. After the webinar, the speakers responded to attendee questions time didn’t permit us to address live. We’re pleased to share those responses with the readers of Ampersand. Read more